Cargando…
Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006671/ https://www.ncbi.nlm.nih.gov/pubmed/33403801 http://dx.doi.org/10.1002/ehf2.13179 |
_version_ | 1783672352637190144 |
---|---|
author | Ahlgrim, Christoph Seiler, Florian Birkner, Philipp Staudacher, Dawid Leander Grundmann, Sebastian Bode, Christoph Pottgiesser, Torben |
author_facet | Ahlgrim, Christoph Seiler, Florian Birkner, Philipp Staudacher, Dawid Leander Grundmann, Sebastian Bode, Christoph Pottgiesser, Torben |
author_sort | Ahlgrim, Christoph |
collection | PubMed |
description | BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascular volumes and possible volume excess in compensated CHF patients over time. METHODS AND RESULTS: This study aims at quantification of blood volume and its components, RCV and PV (raw values and adjusted for sex and anthropometric characteristics, expressed as per cent of the expected normal value), using an abbreviated carbon monoxide (CO) rebreathing method (aCORM) in 14 patients (two women) with systolic CHF at baseline and at a follow‐up visit after approximately 6 months. While a vast heterogeneity was observed concerning RCV (82% to 134% of normalized alues) and PV (72% to 131% of normalized values), the vascular volumes showed a mean change of 1.2% and −1.3% after a mean follow‐up of 183 days. CONCLUSIONS: The vascular volumes including individual volume excess appear to be stable in compensated CHF patients. The reason for this individual volume response concerning both RCV and PV in CHF remains unclear and deserves further clarification. |
format | Online Article Text |
id | pubmed-8006671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80066712021-04-01 Time course of red cell volume and plasma volume over six months in compensated chronic heart failure Ahlgrim, Christoph Seiler, Florian Birkner, Philipp Staudacher, Dawid Leander Grundmann, Sebastian Bode, Christoph Pottgiesser, Torben ESC Heart Fail Short Communications BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascular volumes and possible volume excess in compensated CHF patients over time. METHODS AND RESULTS: This study aims at quantification of blood volume and its components, RCV and PV (raw values and adjusted for sex and anthropometric characteristics, expressed as per cent of the expected normal value), using an abbreviated carbon monoxide (CO) rebreathing method (aCORM) in 14 patients (two women) with systolic CHF at baseline and at a follow‐up visit after approximately 6 months. While a vast heterogeneity was observed concerning RCV (82% to 134% of normalized alues) and PV (72% to 131% of normalized values), the vascular volumes showed a mean change of 1.2% and −1.3% after a mean follow‐up of 183 days. CONCLUSIONS: The vascular volumes including individual volume excess appear to be stable in compensated CHF patients. The reason for this individual volume response concerning both RCV and PV in CHF remains unclear and deserves further clarification. John Wiley and Sons Inc. 2021-01-05 /pmc/articles/PMC8006671/ /pubmed/33403801 http://dx.doi.org/10.1002/ehf2.13179 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Short Communications Ahlgrim, Christoph Seiler, Florian Birkner, Philipp Staudacher, Dawid Leander Grundmann, Sebastian Bode, Christoph Pottgiesser, Torben Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title | Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title_full | Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title_fullStr | Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title_full_unstemmed | Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title_short | Time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
title_sort | time course of red cell volume and plasma volume over six months in compensated chronic heart failure |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006671/ https://www.ncbi.nlm.nih.gov/pubmed/33403801 http://dx.doi.org/10.1002/ehf2.13179 |
work_keys_str_mv | AT ahlgrimchristoph timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT seilerflorian timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT birknerphilipp timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT staudacherdawidleander timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT grundmannsebastian timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT bodechristoph timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure AT pottgiessertorben timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure |